Mealey's (February 17, 2022, 12:41 PM EST) -- RICHMOND, Va. — A Fourth Circuit U.S. Court of Appeals panel should affirm a federal district court’s dismissal of federal securities law claims against Syneos Health Inc. and certain of its current and former senior executives (collectively, Syneos) over alleged misrepresentations they made in attempting to secure a merger deal with another company because shareholders failed to sufficiently plead any actionable misstatements or omissions or scienter in pleading their claims, Syneos argues in a Feb. 14 appellee brief....